Business Wire

MulteFire Alliance Completes Its IoT Optimized Specification

Del

The MulteFire Alliance, an independent, diverse and international member-driven consortium that is defining and promoting MulteFire® technology – LTE technology operating in unlicensed bands – today announced the completion of its Release 1.1 specification that is optimized for IoT. Adding support for eMTC-U and NB-IoT-U, as well as support for additional spectrum bands, the Release 1.1 specification delivers more robust wireless network capabilities for Industrial IoT and Enterprises to meet their specific requirements for performance, latency, security and mobility.

“The Release 1.1 Technical Specification is a significant achievement offering an optimized specification for IoT and support for additional spectrum bands,” said Mazen Chmaytelli, president, MulteFire Alliance. “This milestone could not have been reached without the dedication and commitment of the Technical Specification Group members who have worked tirelessly to evolve MulteFire technology to meet the needs of industrial IoT and enterprise.”

“MulteFire 1.0 is a novel technology that was designed to create new wireless networks by operating LTE-based technology standalone in unlicensed or shared spectrum bands,” said Asimakis Kokkos, chair, Technical Specification Group, MulteFire Alliance and head of Industry Environment Strategy, Nokia. “MulteFire 1.1 takes the potential of this technology even further by improving on the performance of MulteFire 1.0 for the global 5 GHz unlicensed band, and by adding new capabilities and support for additional spectrum bands.”

Specification Highlights

The MulteFire Release 1.1 specification includes the following features:

  • Added Additional Spectrum Bands Focusing on IoT and Expanded IoT Services with Low Power Wide Area Support
    • Adds eMTC-U support for moderate data rate applications in the global 2.4 GHz unlicensed band
    • Adds NB-IoT-U support for narrowband applications in the regional 800/900 MHz unlicensed bands
    • Adds MulteFire 1.9 GHz support (for the unlicensed part in 3GPP defined Band 39), also known as sXGP in Japan, which is ready for commercial deployment in Japan with support from the XGP Forum and an ecosystem of TD-LTE devices in place that support Band 39 today
  • Enhanced MulteFire 1.0 Broadband Services in the Global 5 GHz Unlicensed Band
    • Delivers more robust mobility in up to 50 km/h speeds with the addition of Autonomous UE Mobility (AUM) which performs autonomous handover without explicit network command
    • Allows for faster uplink data transmissions with Grant-less Uplink (GUL), whereby the UE can start transmitting immediately
    • Supports improved downlink coverage with Wideband Coverage Enhancements (WCE)
    • Adds Self-Organizing Networks (SON) capabilities

A new white paper, Release 1.1 Technical Overview, provides more details and is available to download at www.MulteFire.org/white-papers.

The Release 1.1 specification will be published to MulteFire Alliance members in January 2019 and will be made available for download by anyone with an interest in MulteFire technology by mid-year. For information on joining the MulteFire Alliance, visit www.MulteFire.org/join.

About the MulteFire Alliance

The MulteFire Alliance is an international association dedicated to building a global ecosystem in support of the common interests of members, developers and users in the application of Long Term Evolution (LTE) and next-generation mobile cellular technology, such as 5G New Radio, in configurations that use unlicensed or shared radio spectrum. For more information about MulteFire, its benefits, or how to become a member of the MulteFire Alliance, visit www.multefire.org.

Contact information

MulteFire Alliance
Lori Mesecke, +1-503-459-9150
press@multefire.org

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Pioneering Project for Pharmaceutics – Vifor Pharma and the University of Basel are Jointly Establishing the World’s First Research Professorship for Nanopharmaceutical and Regulatory Science26.5.2019 07:00:00 CESTPressemelding

Nanopharmaceutics promises ground-breaking innovation in the development of medicines: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190526005014/en/ The Vifor Pharma Group is endowing two professorships for Nanopharmaceutical and Regulatory Science at the University of Basel The commitment by Vifor Pharma and the University of Basel is aimed at ensuring Switzerland has the specialist knowledge and equipment needed to compete globally in this important emerging area of life sciences With this decision, Vifor Pharma is demonstrating its commitment to Switzerland as a world-leading location for pharmaceutical research and development Nanomedicines are playing an increasingly important role in the development of innovative new medications. These drugs are able to overcome specific cellular barriers in the human body with a view to targeting their effect even more precisely. Nanopharmacy therefore promises to help advance medic

XINHUANET: Promotion Event of The Most Beautiful Shooting Location in China Held During Cannes Film Festival25.5.2019 18:20:00 CESTPressemelding

On May 16 (local time), an event was held at the 72nd Cannes Film Festival to recommend China’s most beautiful shooting locations on the theme of “Fascinating China.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190525005008/en/ The representative from Cannes Convention Bureau (1st L), Michel Chevillon (C), vice president of the French Riviera Chamber of Commerce and Industry and head of hotel association, and Adeline CHAUVEAU (3rd R), officer in charge of film and television projects from French Embassy to China, pose for a group photo with the representatives from the cities awarded for "The most beautiful shooting location in China." (Photo: Business Wire) In the event, the Yellow Sea National Forest Park in Dongtai, Jiangsu Province, the One Hundred Mile Azalea Forest in Bijie, Guizhou Province, Siming District of Xiamen, Fujian Province, and the Li Autonomous County in Lingshui, Hainan Province were on the list. The p

Knopp Biosciences Presents Positive Preclinical Data for Lead Neonatal Epilepsy Drug Candidate at 2019 Antiepileptic Drug and Device Trials XV Conference24.5.2019 14:00:00 CESTPressemelding

Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases of high unmet need, today presented in vitro and in vivo data for the company’s lead molecule for the targeted treatment of KCNQ2-neonatal epileptic encephalopathy (KCNQ2-NEE) at the Antiepileptic Drug and Device Trials XV Conference in Miami, Florida. KCNQ2-NEE, a rare infant genetic epilepsy, results from mutations in genes encoding the Kv7.2/Kv7.3 ion channel, leading to frequent seizures and profound developmental delay. The preclinical data were presented by Steven Dworetzky, Ph.D., Knopp’s Chief Scientific Officer, a longtime Kv7 researcher who led the group that first cloned the Kv7.2 and Kv7.3 genes during his former tenure with the Bristol-Myers Squibb Co. Dr. Dworetzky presented results demonstrating the in vitro nanomolar activity of KB-3061 and its significant seizure protection in the maximal electroshock mo

Accelerate Your Business in South Korea Through 2019 K-Startup Grand Challenge24.5.2019 10:20:00 CESTPressemelding

Entrepreneurs from across the globe should set their sights on participating in the 2019 K-Startup Grand Challenge. Supported by the Ministry of SMEs and Startups and National IT Industry Promotion Agency (NIPA) of South Korea, the initiative provides invaluable support and comprehensive resources to early age startups. Applications for the K-Startup Grand Challenge are currently being accepted through June 14, 2019. In order to advance in the program, teams must pass a regional audition. A judging panel of startup ecosystem experts and Korean accelerators will select 40 teams to participate in an enriching 3.5 month-long acceleration program in Korea. The selected teams will have exclusive access to free office space at the Startup Campus in Pangyo Techno Valley, one-on-one mentoring, information sessions, coaching on Korean and Asian business culture and the chance to attend insightful seminars on accounting regulations to tax laws, patents and more. Opportunities for networking with

New Investigational Clinical Data for Ipsen’s Oncology Products in 11 Solid Tumor Types to Be Presented at 2019 ASCO Annual Meeting24.5.2019 05:00:00 CESTPressemelding

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that new data from clinical studies on investigational uses of cancer medicines cabozantinib (Cabometyx®), liposomal irinotecan (Onivyde®), and lanreotide autogel (Somatuline®, marketed as Somatuline Depot® in the United States) will be presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting. The meeting takes place in Chicago, Illinois, U.S., 31 May–4 June 2019; data featuring Ipsen medicines includes: New data from the Phase 3 CELESTIAL trial on the association of adverse events with efficacy outcomes for cabozantinib in patients with advanced hepatocellular carcinoma Overview of the Phase 3 COSMIC-312 trial of cabozantinib in combination with atezolizumab vs sorafenib in patients with advanced hepatocellular carcinoma who have not received previous systemic anticancer therapy First Phase 2 data from the CaboGIST study (trial 1317) from the European Organization for Research and Treatment of

The Posiflex Group Showcases an Ecosystem of Connected Solution Endpoints with IoT Remote Monitoring at Computex 201924.5.2019 01:00:00 CESTPressemelding

For the Computex 2019 show, The Posiflex Group is featuring leading solution technology from the family of brands as a fully Serviced IoT Ecosystem. Solution end points include: Connected Modular Kiosks, POS Terminals, and Digital Signage solutions from Posiflex and KIOSK Information Systems Smart Medical Displays with gesture controls from Portwell Connected Gaming Solutions with Player Tracking Technology from Portwell subsidiary, Ganlot The booth display is based on common field service endpoints represented in a European Manor Destination Resort setting. Field solutions for an array of vertical market applications include QSR ordering, cinema ticketing, fashion retail customer loyalty, interactive signage, hotel / medical center check-in and bill pay, as well as casino gaming technology. This year, in addition to their renowned POS product suite, Posiflex will be featuring newly introduced Modular Kiosk platforms (co-designed by KIOSK and Posiflex), which are configure-to-order sta